<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37271020</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1877-0665</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of physical and rehabilitation medicine</Title><ISOAbbreviation>Ann Phys Rehabil Med</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of exercise training on the dyspnoea of individuals with long COVID: A randomised controlled multicentre trial.</ArticleTitle><Pagination><StartPage>101765</StartPage><MedlinePgn>101765</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rehab.2023.101765</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1877-0657(23)00036-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19-related acute respiratory distress syndrome (CARDS) is a severe evolution of the Sars-Cov-2 infection and necessitates intensive care. COVID-19 may subsequently be associated with long COVID, whose symptoms can include persistent respiratory symptoms up to 1 year later. Rehabilitation is currently recommended by most guidelines for people with this condition.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the effects of exercise training rehabilitation (ETR) on dyspnoea and health-related quality of life measures in people with continuing respiratory discomfort following CARDS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this multicentre, two-arm, parallel, open, assessor-blinded, randomised controlled trial, we enroled adults previously admitted with CARDS to 3 French intensive care units who had been discharged at least 3 months earlier and who presented with an mMRC dyspnoea scale score &gt; 1. Participants received either ETR or standard physiotherapy (SP) for 90 days. The primary outcome was dyspnoea, as measured by the Multidimensional Dyspnoea Profile (MDP), at day 0 (inclusion) and after 90 days of physiotherapy. Secondary outcomes were the mMRC and 12-item Short-Form Survey scores.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between August 7, 2020, and January 26, 2022, 487 participants with CARDS were screened for inclusion, of whom 60 were randomly assigned to receive either ETR (n&#xa0;=&#xa0;27) or SP (n&#xa0;=&#xa0;33). Mean MDP following ETR was 42% lower than after SP (26.15&#xa0;vs. 44.76); a difference of -18.61 (95% CI -27.78 to -9.44; p&lt;10<sup>-4</sup>).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">People who were still suffering from breathlessness three months after being discharged from hospital with CARDS had significantly improved dyspnoea scores when treated with ETR therapy for 90 days unlike those who only received SP. Study registered 29/09/2020 on Clinicaltrials.gov (NCT04569266).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romanet</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Groupe Hospitalier Paris Saint Joseph, Paris, France. Electronic address: cromanet@ghpsj.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wormser</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Groupe Hospitalier Paris Saint Joseph, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fels</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Groupe Hospitalier Paris Saint Joseph, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Hopital Cochin - Port Royal, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudat</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Groupe Hospitalier Paris Saint Joseph, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacco</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Groupe Hospitalier Paris Saint Joseph, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruel</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Groupe Hospitalier Paris Saint Joseph, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plantef&#xe8;ve</LastName><ForeName>Ga&#xeb;tan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Centre Hospitalier Victor Dupouy, Argenteuil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pene</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Hopital Cochin - Port Royal, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatellier</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Groupe Hospitalier Paris Saint Joseph, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philippart</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Groupe Hospitalier Paris Saint Joseph, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04569266</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Phys Rehabil Med</MedlineTA><NlmUniqueID>101502773</NlmUniqueID><ISSNLinking>1877-0657</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2023 Oct;176(10):JC117. doi: 10.7326/J23-0073</RefSource><PMID Version="1">37782920</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Dyspnoea</Keyword><Keyword MajorTopicYN="N">HRQOL</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Physiotherapy</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>4</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37271020</ArticleId><ArticleId IdType="pmc">PMC10237688</ArticleId><ArticleId IdType="doi">10.1016/j.rehab.2023.101765</ArticleId><ArticleId IdType="pii">S1877-0657(23)00036-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M., et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet Lond Engl. 2020;395:1763&#x2013;1770. doi: 10.1016/S0140-6736(20)31189-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31189-2</ArticleId><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M., Hajage D., Demoule A., Pham T., Combes A., Dres M., et al. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47:60&#x2013;73. doi: 10.1007/s00134-020-06294-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06294-x</ArticleId><ArticleId IdType="pmc">PMC7674575</ArticleId><ArticleId IdType="pubmed">33211135</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARDS Definition Task Force Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526&#x2013;2533. doi: 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5669</ArticleId><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lascarrou J.-B. COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions. Lancet Respir Med. 2021;9:1345&#x2013;1347. doi: 10.1016/S2213-2600(21)00381-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00381-7</ArticleId><ArticleId IdType="pmc">PMC8510630</ArticleId><ArticleId IdType="pubmed">34653373</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhont S., Derom E., Van Braeckel E., Depuydt P., Lambrecht B.N. The pathophysiology of &#x201c;happy&#x201d; hypoxemia in COVID-19. Respir Res. 2020;21:198. doi: 10.1186/s12931-020-01462-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01462-5</ArticleId><ArticleId IdType="pmc">PMC7385717</ArticleId><ArticleId IdType="pubmed">32723327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin M.J., Laghi F., Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202:356&#x2013;360. doi: 10.1164/rccm.202006-2157CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202006-2157CP</ArticleId><ArticleId IdType="pmc">PMC7397783</ArticleId><ArticleId IdType="pubmed">32539537</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L., Chiumello D., Caironi P., Busana M., Romitti F., Brazzi L., et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099&#x2013;1102. doi: 10.1007/s00134-020-06033-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06033-2</ArticleId><ArticleId IdType="pmc">PMC7154064</ArticleId><ArticleId IdType="pubmed">32291463</ArticleId></ArticleIdList></Reference><Reference><Citation>Dres M., Dub&#xe9; B.-P., Mayaux J., Delemazure J., Reuter D., Brochard L., et al. Coexistence and impact of limb muscle and diaphragm weakness at time of liberation from mechanical ventilation in medical intensive care unit patients. Am J Respir Crit Care Med. 2017;195:57&#x2013;66. doi: 10.1164/rccm.201602-0367OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201602-0367OC</ArticleId><ArticleId IdType="pubmed">27310484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieske L., Dettling-Ihnenfeldt D.S., Verhamme C., Nollet F., van Schaik I.N., Schultz M.J., et al. Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19:196. doi: 10.1186/s13054-015-0937-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0937-2</ArticleId><ArticleId IdType="pmc">PMC4427976</ArticleId><ArticleId IdType="pubmed">25928709</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge M.S., Tansey C.M., Matt&#xe9; A., Tomlinson G., Diaz-Granados N., Cooper A., et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293&#x2013;1304. doi: 10.1056/NEJMoa1011802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1011802</ArticleId><ArticleId IdType="pubmed">21470008</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D., Savale L., Noel N., Meyrignac O., Colle R., Gasnier M., et al. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022;31 doi: 10.1183/16000617.0185-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou K.M., Vasarmidi E., Russell A.-M., Andrejak C., Crestani B., Delcroix M., et al. European Respiratory Society statement on long COVID follow-up. Eur Respir J. 2022;60 doi: 10.1183/13993003.02174-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02174-2021</ArticleId><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez D.C., Normand K., Zhaoyun Y., Torres-Castro R. Long term impact of COVID-19: a systematic review of the literature and meta-analysis. Biomedicines. 2021;9:900. doi: 10.3390/biomedicines9080900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080900</ArticleId><ArticleId IdType="pmc">PMC8389585</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M., Carone M., Clini E.M., Paneroni M., Lazzeri M., Lanza A., et al. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper. Respir Int Rev Thorac Dis. 2020;99:493&#x2013;499. doi: 10.1159/000508399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000508399</ArticleId><ArticleId IdType="pmc">PMC7316664</ArticleId><ArticleId IdType="pubmed">32428909</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas P., Baldwin C., Bissett B., Boden I., Gosselink R., Granger C.L., et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66:73&#x2013;82. doi: 10.1016/j.jphys.2020.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2020.03.011</ArticleId><ArticleId IdType="pmc">PMC7165238</ArticleId><ArticleId IdType="pubmed">32312646</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit M.A., Holland A.E., Singh S.J., Tonia T., Wilson K.C., Troosters T. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force. Eur Respir J. 2020;56 doi: 10.1183/13993003.02197-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02197-2020</ArticleId><ArticleId IdType="pmc">PMC7427118</ArticleId><ArticleId IdType="pubmed">32817258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kin&#xe9;sith&#xe9;rapie - R&#xe9;entrainement &#xe0; l'effort au cours des sympt&#xf4;mes prolong&#xe9;s de la COVID-19. Haute Aut Sant&#xe9;. 2021;4</Citation></Reference><Reference><Citation>Tipping C.J., Harrold M., Holland A., Romero L., Nisbet T., Hodgson C.L. The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review. Intensive Care Med. 2017;43:171&#x2013;183. doi: 10.1007/s00134-016-4612-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4612-0</ArticleId><ArticleId IdType="pubmed">27864615</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly B., Salisbury L., O'Neill B., Geneen L., Douiri A., Grocott M.P.W., et al. Exercise rehabilitation following intensive care unit discharge for recovery from critical illness: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2016;7:520&#x2013;526. doi: 10.1002/jcsm.12146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12146</ArticleId><ArticleId IdType="pmc">PMC5114628</ArticleId><ArticleId IdType="pubmed">27891297</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba G.A., Ziehr D.R., Rouvina J.N., Hariri L.P., Knipe R.S., Medoff B.D., et al. Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. EClinicalMedicine. 2021;39 doi: 10.1016/j.eclinm.2021.101066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101066</ArticleId><ArticleId IdType="pmc">PMC8401400</ArticleId><ArticleId IdType="pubmed">34476393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J., Piroth L., Epaulard O., Le Turnier P., Mentr&#xe9; F., Bachelet D., et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021;27:1041.e1&#x2013;1041.e4. doi: 10.1016/j.cmi.2021.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Banzett R.B., O'Donnell C.R., Guilfoyle T.E., Parshall M.B., Schwartzstein R.M., Meek P.M., et al. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J. 2015;45:1681&#x2013;1691. doi: 10.1183/09031936.00038914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00038914</ArticleId><ArticleId IdType="pmc">PMC4450151</ArticleId><ArticleId IdType="pubmed">25792641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581&#x2013;586. doi: 10.1136/thx.54.7.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit M.A., Singh S.J., Garvey C., ZuWallack R., Nici L., Rochester C., et al. An official American Thoracic Society/European Respiratory Society Statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13&#x2013;e64. doi: 10.1164/rccm.201309-1634ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201309-1634ST</ArticleId><ArticleId IdType="pubmed">24127811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R., Marinov B., Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev. 2013;22:178&#x2013;186. doi: 10.1183/09059180.00000513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09059180.00000513</ArticleId><ArticleId IdType="pmc">PMC9487382</ArticleId><ArticleId IdType="pubmed">23728873</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosbois J.-M., Gicquello A., Langlois C., Le Rouzic O., frederic Bart, Wallaert B., et al. Long-term evaluation of home-based pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:2037&#x2013;2044. doi: 10.2147/COPD.S90534.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S90534</ArticleId><ArticleId IdType="pmc">PMC4590573</ArticleId><ArticleId IdType="pubmed">26445534</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz M.B., Littenberg B., Mahler D.A. Dyspnea ratings for prescribing exercise intensity in patients with COPD. Chest. 1996;109:1169&#x2013;1175. doi: 10.1378/chest.109.5.1169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.109.5.1169</ArticleId><ArticleId IdType="pubmed">8625662</ArticleId></ArticleIdList></Reference><Reference><Citation>Sympt&#xf4;mes prolong&#xe9;s suite &#xe0; une COVID-19 de l'adulte - diagnostic et prise en charge. Haute Aut Sant&#xe9; n.d. https://www.has-sante.fr/jcms/p_3237041/fr/symptomes-prolonges-suite-a-une-covid-19-de-l-adulte-diagnostic-et-prise-en-charge (accessed September 17, 2022).</Citation></Reference><Reference><Citation>Ekstr&#xf6;m M., Bornefalk H., Sk&#xf6;ld C.M., Janson C., Blomberg A., Sandberg J., et al. Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study. Eur Respir J. 2021;57 doi: 10.1183/13993003.02823-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02823-2020</ArticleId><ArticleId IdType="pubmed">33334935</ArticleId></ArticleIdList></Reference><Reference><Citation>Smondack P., Gravier F.-&#xc9;., Prieur G., Repel A., Muir J.-F., Cuvelier A., et al. Kin&#xe9;sith&#xe9;rapie et COVID-19 : de la r&#xe9;animation &#xe0; la r&#xe9;habilitation &#xe0; domicile. Synth&#xe8;se des recommandations internationales. Rev Mal Respir. 2020;37:811&#x2013;822. doi: 10.1016/j.rmr.2020.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmr.2020.09.001</ArticleId><ArticleId IdType="pmc">PMC7552976</ArticleId><ArticleId IdType="pubmed">33067078</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet Lond Engl. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S., Moik F., Klok F.A., Gattinger D., Petrovic M., Vonbank K., et al. Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. 2022;101:593&#x2013;601. doi: 10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum T.V., Aal&#xf8;kken T.M., Br&#xf8;nstad E., Aarli B., Ikdahl E., Lund K.M.A., et al. Dyspnoea, lung function and CT findings 3&#x2005;months after hospital admission for COVID-19. Eur Respir J. 2021;57 doi: 10.1183/13993003.03448-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H., van der Hoeven J.G., Corsten S., Janssen I., Ewalds E., Simons K.S., et al. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA. 2022;327:559&#x2013;565. doi: 10.1001/jama.2022.0040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.0040</ArticleId><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J., Ben&#xed;tez I.D., Carmona P., Santisteve S., Monge A., Moncus&#xed;-Moix A., et al. Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort. Chest. 2021;160:187&#x2013;198. doi: 10.1016/j.chest.2021.02.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.02.062</ArticleId><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q., Li J., Hu X., Bai Y., Zheng Y., Gao Z. Follow-ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: a systematic review and meta-analysis. Front Med. 2021;8 doi: 10.3389/fmed.2021.702635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.702635</ArticleId><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosbois J.-M., Gephine S., Kyheng M., Henguelle J., Rouzic O.L., Saey D., et al. Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD. BMJ Open Respir Res. 2022;9 doi: 10.1136/bmjresp-2021-001160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001160</ArticleId><ArticleId IdType="pmc">PMC8796257</ArticleId><ArticleId IdType="pubmed">35078826</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashimoto Y., Ando M., Sano A., Saeki S., Nishikawa Y., Fukuda K., et al. Effect of pulmonary rehabilitation programs including lower limb endurance training on dyspnea in stable COPD: a systematic review and meta-analysis. Respir Investig. 2020;58:355&#x2013;366. doi: 10.1016/j.resinv.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2020.05.010</ArticleId><ArticleId IdType="pubmed">32660900</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Chen J., Chen X., Lin L., Yan H., Zhou Y., et al. Impact of resistance training in subjects with COPD: a systematic review and meta-analysis. Respir Care. 2015;60:1130&#x2013;1145. doi: 10.4187/respcare.03598.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.03598</ArticleId><ArticleId IdType="pubmed">26015595</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Zhang W., Yang Y., Zhang J., Li Y., Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther Clin Pract. 2020;39 doi: 10.1016/j.ctcp.2020.101166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctcp.2020.101166</ArticleId><ArticleId IdType="pmc">PMC7118596</ArticleId><ArticleId IdType="pubmed">32379637</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A., Franco-L&#xf3;pez F., Buend&#xed;a-Romero &#xc1;., Mart&#xed;nez-Cava A., S&#xe1;nchez-Agar J.A., S&#xe1;nchez-Alcaraz Mart&#xed;nez B.J., et al. Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: a randomized controlled trial. Scand J Med Sci Sports. 2022;32:1791&#x2013;1801. doi: 10.1111/sms.14240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sms.14240</ArticleId><ArticleId IdType="pmc">PMC9538729</ArticleId><ArticleId IdType="pubmed">36111386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockele L.F., Sachet Affonso J.V., Rossi D., Eibel B. Pulmonary and functional rehabilitation improves functional capacity, pulmonary function and respiratory muscle strength in post COVID-19 patients: pilot clinical trial. Int J Environ Res Public Health. 2022;19:14899. doi: 10.3390/ijerph192214899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192214899</ArticleId><ArticleId IdType="pmc">PMC9691070</ArticleId><ArticleId IdType="pubmed">36429613</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159:321&#x2013;340. doi: 10.1164/ajrccm.159.1.ats898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.159.1.ats898</ArticleId><ArticleId IdType="pubmed">9872857</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J., Balagny P., Arnoult F., Mangin L., Bancal C., d'Ortho M.-P., et al. Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Front Physiol. 2021;11 doi: 10.3389/fphys.2020.614590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.614590</ArticleId><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteleux B., Henrot P., Ernst R., Grassion L., Raherison-Semjen C., Beaufils F., et al. Respiratory rehabilitation for Covid-19 related persistent dyspnoea: a one-year experience. Respir Med. 2021;189 doi: 10.1016/j.rmed.2021.106648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106648</ArticleId><ArticleId IdType="pmc">PMC8511554</ArticleId><ArticleId IdType="pubmed">34689061</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheiber B., Spiegl C., Wiederin C., Schifferegger E., Schiefermeier-Mach N. Post-COVID-19 rehabilitation: perception and experience of Austrian physiotherapists and physiotherapy students. Int J Environ Res Public Health. 2021;18:8730. doi: 10.3390/ijerph18168730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18168730</ArticleId><ArticleId IdType="pmc">PMC8394152</ArticleId><ArticleId IdType="pubmed">34444477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>